Extent of Donor Site Morbidity after Scaphoid Repair Surgery Using the Medial Femoral Condyle

Overview

About this study

The purpose of the study is to determine the extent of donor site morbidity after harvesting the medial femoral condyle for scaphoid nonunion treatment. The outcomes being measured are: superficial infection, deep infection, pain (short term), pain (long term), knee function and quality of  scar.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Males or females age 18 to 89 years.
  • Patients that have undergone scaphoid nonunion repair surgery using the medial femoral condyle between 1/1/1970 and 11/1/2016
  • Follow up post-surgery

Exclusion Criteria:

  • No follow up data
  • Femoral medial condyle grafts used for other surgeries than the scaphoid nonunion
  • Scaphoid nonunion repair surgery using other grafts than femoral medial condyle

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Allen Bishop, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20306574

Mayo Clinic Footer